McKesson Corporation
MCKHealthcareNASDAQMedical Distribution · Last scanned Jul 17, 2026
Scan Results
Daily timeframeHeadquartered within the healthcare sector, McKesson Corporation focuses on Medical Distribution services and products. McKesson Corporation provides healthcare services in the United States and internationally. With a market capitalization of $98.50B, it sits in large-cap territory. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions.
Market Cap
$98.50B
Beta
0.32
P/E (TTM)
20.75
P/E (Fwd)
16.71
EPS (TTM)
$40.55
EPS (Fwd)
$50.34
ROE
—
ROA
5.0%
Cash
$3.98B
Total Debt
$8.79B
Free CF
$5.66B
52W Change
18.4%
Annual Financials
Cash vs Debt
The company holds $3.98B in cash, though total debt stands at $8.79B. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Free cash flow comes in at $5.66B, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROA of 5.0% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $276.71B (2023) to $403.43B (2026), reflecting a 46% increase over the period.
With a beta below 0.7, McKesson Corporation typically sees smaller price swings than the overall market, offering a degree of stability during turbulent periods. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing MCK.